Immunometabolic coevolution defines unique microenvironmental niches in ccRCC Journal Article


Authors: Tang, C.; Xie, A. X.; Liu, E. M.; Kuo, F.; Kim, M.; DiNatale, R. G.; Golkaram, M.; Chen, Y. B.; Gupta, S.; Motzer, R. J.; Russo, P.; Coleman, J.; Carlo, M. I.; Voss, M. H.; Kotecha, R. R.; Lee, C. H.; Tansey, W.; Schultz, N.; Hakimi, A. A.; Reznik, E.
Article Title: Immunometabolic coevolution defines unique microenvironmental niches in ccRCC
Abstract: Tumor cell phenotypes and anti-tumor immune responses are shaped by local metabolite availability, but intratumoral metabolite heterogeneity (IMH) and its phenotypic consequences remain poorly understood. To study IMH, we profiled tumor/normal regions from clear cell renal cell carcinoma (ccRCC) patients. A common pattern of IMH transcended all patients, characterized by correlated fluctuations in the abundance of metabolites and processes associated with ferroptosis. Analysis of intratumoral metabolite-RNA covariation revealed that the immune composition of the microenvironment, especially the abundance of myeloid cells, drove intratumoral metabolite variation. Motivated by the strength of RNA-metabolite covariation and the clinical significance of RNA biomarkers in ccRCC, we inferred metabolomic profiles from the RNA sequencing data of ccRCC patients enrolled in 7 clinical trials, and we ultimately identifyied metabolite biomarkers associated with response to anti-angiogenic agents. Local metabolic phenotypes, therefore, emerge in tandem with the immune microenvironment, influence ongoing tumor evolution, and are associated with therapeutic sensitivity. © 2023 The Author(s)
Keywords: transcriptomics; tumor marker; renal cell carcinoma; kidney neoplasms; rna; kidney tumor; carcinoma, renal cell; carcinoma; bone marrow cell; myeloid cells; tumor microenvironment; metabolomics; metabolites; imputation; intratumoral heterogeneity; cancer metabolism; humans; human; immune microenvironment; biomarkers, tumor; immunometabolism
Journal Title: Cell Metabolism
Volume: 35
Issue: 8
ISSN: 1550-4131
Publisher: Elsevier Inc.  
Date Published: 2023-08-08
Start Page: 1424
End Page: 1440.e5
Language: English
DOI: 10.1016/j.cmet.2023.06.005
PUBMED: 37413991
PROVIDER: scopus
PMCID: PMC10603615
DOI/URL:
Notes: The MSK Cancer Center Support Grant (P30 CA008748) is acknowledged in the PDF -- Corresponding authors are MSK authors: A. Ari Hakimi and Ed Reznik -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Jonathan Coleman
    343 Coleman
  2. Paul Russo
    581 Russo
  3. Robert Motzer
    1243 Motzer
  4. Martin Henner Voss
    288 Voss
  5. Yingbei Chen
    398 Chen
  6. Nikolaus D Schultz
    487 Schultz
  7. Abraham Ari Hakimi
    324 Hakimi
  8. Maria Isabel Carlo
    162 Carlo
  9. Eduard Reznik
    103 Reznik
  10. Chung-Han   Lee
    157 Lee
  11. Fengshen Kuo
    81 Kuo
  12. Minwei Liu
    24 Liu
  13. Sounak Gupta
    32 Gupta
  14. Ritesh Rajesh Kotecha
    92 Kotecha
  15. Wesley Tansey
    15 Tansey
  16. Minsoo Kim
    8 Kim
  17. Cerise Tang
    11 Tang
  18. Amy Xie
    6 Xie